Medical Oncology: translational research in esophagogastric carcinoma
Focus of research
Translational research in esophagogastric carcinoma
I coordinate 5 clinical trials wherein I also perform translational research
ACTION: a phase Ib study on the addition of Nab-Paclitaxel to capecitabine and oxaliplatin in the first line treatment of metastatic esophagogastric carcinoma
PERFECT: PDL-1 targetin in resectable esophageal cancer: a phase II feasibility study of Atezolizumab and chemoradiation
REPEAT: Regorafenib in combination with paclitaxel in advanced esophagogastric carcinoma, a phase 1b study
SOX: feasibility study of adjuvant treatment with S-1 and oxaliplatin in patients with resectable esophageal cancer
TRAP: feasibility study of chemoradiation, Trastuzumab and Pertuzumab in resectable HER2+ esophageal carcinoma
